EN
HI

Welcure Drugs & Pharmaceuticals Share price

WELCURE

MiscellaneousSmall

11.52

0.48 (-4.00%)
Last updated on 30 May, 2025 | 15:59 IST
BUYSELL
Today's High

12.60

Today's Low

11.40

52 Week Low

4.30

52 Week High

15.81

The current prices are delayed, login to your account for live prices

Welcure Drugs & Pharmaceuticals Chart

Welcure Drugs & Pharmaceuticals Share Key Metrics

Volume
2.53 L
Market Cap
129.61 CR
LTQ@LTP
100@11.52
ATP
11.82
Var Margin
100 %
Circuit Range
11.4-12.6
Delivery %
0 %
Value
29.91 L
ASM/GSM
No
Market Lot
1

Welcure Drugs & Pharmaceuticals Futures & Options

Data Not Found

Welcure Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2025-05-29Audited Results
2025-05-14Others
2025-02-14Quarterly Results
DateEvent TypeAgenda
2025-05-29Board MeetingAudited Results
2025-05-14Board MeetingOthers
2025-02-14Board MeetingQuarterly Results

Welcure Drugs & Pharmaceuticals News

No Data Found

About Welcure Drugs & Pharmaceuticals

NSE : 0  
BSE : 524661  
ISIN : INE331C01017  

Welcure Drugs and Pharmaceuticals Limited (hereinafter referred to as ''The Company'' or ''WDPL'') was incorporated as a Public Limited Company under the Companies Act 1956 on 4th June 1992 and obtained the certificate of commencement of business on 19th June 1992. The registered office of the Company is situated at E-1052. Saraswati Vihar Delhi - 110 034.PRESENT BUSINESSPresently the Company is engaged in the business of manufacture and marketing of pharmaceuticals formulations in the form of tablets capsules and dry syrups. The Company is manufacturing over hundred varieties of formulations including antibiotics sulpha drugs vitamins analgesics antipyretics corticosteroids anti-malarials anti-dysentery anti-tuberculosis anti-diabetics tranquilisers sedatives and gastro intestinals. The products of the company have already been well accepted in the domestic markets and the Company has an established customer base.SWOT ANALYSISStrengths1.One of the Promoters is having over two decades and the other two promoters are having over a decade experience in the pharmaceutical industry.2.The Plant & Machinery taken by the company is a multipurpose plant on which other drugs can be produced apart from what company intends to manufacture.3.The technolgy required to manufacture of the drugs is indegenously available.4.Approval of first floor of factory by Drugs Control Department to systematically and properly utilise the space for expanded capacity.5.Major portion of bulk drugs will be used for captive consumption for manufacture of pharmaceuticals formulations.6.With the completion of the bulk drug unit the Company will have integrated facilities to manufacture intermediates bulk drugs and formulations.7.Subsidiary Company A.K.Laboratories Ltd. is producing 6 APA a critical drug intermediate used for manufacture of life saving antibiotic drugs like viz. Ampicillin Amoxycillin Cloxacillin and Cephalexin.Weaknesses1.Commercial production of the existing formulation unit was delayed by five months and bulk drug unit is expected to be delayed by approximately 18 months.2.The cost of the project and means of finance have not been appraised by any Bank/Financial Institution.3.Delay in Government approvals may affect the timely implementation of the project.Opportunities1.Products have a growing domestic market and good export potential.Threats1. Competition from existing and proposed manufacturers as is normal and prevalent in any industry.2.Changes in Drug Policy announced by the Government from time to time may have an impact on the operations of the Company.

Welcure Drugs & Pharmaceuticals Management

NamePosition
Mr. Altaf Hussain Shah Managing Director & CFO
Mrs. Deepika Krishnan Iyer Ind. Non-Executive Director
Mr. Ashish Abbi Ind. Non-Executive Director
Mr. Suraj Chagan Solanki Non Exe.Non Ind.Director
Read More

Welcure Drugs & Pharmaceuticals FAQs

The Buying Price of Welcure Drugs & Pharmaceuticals share is 11.52 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Welcure Drugs & Pharmaceuticals share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Welcure Drugs & Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Welcure Drugs & Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Welcure Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 40.19 & 2.51 with sector averages, along with growth rates and financial metrics.

The Market Cap of Welcure Drugs & Pharmaceuticals is 129.61 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Welcure Drugs & Pharmaceuticals share price is 15.81 & 4.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.